Blood Pressure, Coronary Artery Disease, Coronary Artery Stenosis
Conditions
Brief summary
The HYUMC registry is a two-center, real-world registry of percutaneous coronary intervention in patients with coronary artery disease. From January 2012, PCI-treated patients from Hanyang University Seoul Hospitals and Hanyang University Guri Hospitals were enrolled in this registry. The aim of this registry is to examine the long-term clinical outcomes and identify predictors of adverse outcomes following percutaneous coronary intervention conducted at academic hospitals.
Detailed description
In the HYUMC registry, the researchers have gathered and assessed various demographic, laboratory, echocardiographic, and angiographic measurements (both on-admission and during follow-up), as well as conducted questionnaires among patients who underwent percutaneous coronary intervention. The primary focus of this registry is to examine the effects of these parameters on long-term clinical outcomes.
Interventions
DEVICEpercutaneous coronary intervention
patients with CAD undergoing PCI with second generation DES
Sponsors
Hanyang University
Hanyang University Seoul Hospital
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Consecutive patients with CAD who underwent PCI one or more drug eluting stent (DES) with from 2012 at the Division of Cardiology of Hanyang University Seoul Hospital and Hanyang University Guri Hospital, Korea.
Exclusion criteria
* second or subsequent hospitalization records of patients with multiple admissions * patients who died during index hospitalization * patients who treated with first-generation drug eluting stent * patients with an outpatient follow-up record of less than 6 months * patients with insufficient medical records.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| MACCE (major adverse cardiac and cerebrovascular event) | 10-year | the composite of all-cause death, myocardial infarction, stroke, or any revascularization |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| All-cause death | 10-year | death from any cause |
| Myocardial infarction, | 10-year | presence of clinical symptoms with the presence of electrocardiographic changes, or imaging evidence of new loss of viable myocardium or new regional wall motion abnormalities, in conjunction with elevated levels of cardiac biomarker above the 99th percentile upper reference limit |
| Stroke | 10-year | neurological deficit resulting from acute focal damage to the central nervous system due to a vascular cause, requiring hospitalization, and confirmed by a neurologist through imaging findings |
| Any revascularization | 10-year | PCI or coronary artery bypass surgery on either target or nontarget vessels |
Countries
South Korea
Outcome results
None listed